-
17736-25A selective PAR2 agonist that stimulates cell proliferation, phosphatidylinositol hydrolysis, and calcium mobilization in in vitro functional assays (pEC<sub>50</sub>s = 6.7, 5.9, and 6.6, respectively) elicits pronociceptive activity in vivo.
-
17736-5A selective PAR2 agonist that stimulates cell proliferation, phosphatidylinositol hydrolysis, and calcium mobilization in in vitro functional assays (pEC<sub>50</sub>s = 6.7, 5.9, and 6.6, respectively) elicits pronociceptive activity in vivo.
-
16501-1An acetylated synthetic peptide from human calpastatin that strongly inhibits both calpains I and II but not papain or trypsin.
-
16501-100An acetylated synthetic peptide from human calpastatin that strongly inhibits both calpains I and II but not papain or trypsin.
-
16501-500An acetylated synthetic peptide from human calpastatin that strongly inhibits both calpains I and II but not papain or trypsin.
-
A0812-10 mgMast cell stabilizer used to treat seasonal allergic rhinitis.
-
A0812-25 mgMast cell stabilizer used to treat seasonal allergic rhinitis.
-
A0812-5 mgMast cell stabilizer used to treat seasonal allergic rhinitis.
-
14459-1A fluorogenic substrate for activated caspase-3 (Km = 9.7 µM), as well as related caspases caspase activity can be quantified by fluorescent detection of free AFC, which is excited at 400 nm and emits at 505 nm.
-
14459-10A fluorogenic substrate for activated caspase-3 (Km = 9.7 µM), as well as related caspases caspase activity can be quantified by fluorescent detection of free AFC, which is excited at 400 nm and emits at 505 nm.
-
14459-5A fluorogenic substrate for activated caspase-3 (Km = 9.7 µM), as well as related caspases caspase activity can be quantified by fluorescent detection of free AFC, which is excited at 400 nm and emits at 505 nm.
-
14986-1A fluorogenic substrate that can be cleaved specifically by caspase-3.